Pharmacist-led medication review in patients over 65: a randomized, controlled trial in primary care

J. Krska
2001 Age and Ageing  
regular medication review has been recommended for those over 75 and those on multiple drug therapy. Pharmacists are a potential source of assistance in reviewing medication. Evidence of the bene®ts of this process is needed. Objective: to study the effect of medication review led by a pharmacist on resolution of pharmaceutical care issues, medicine costs, use of health and social services and health-related quality of life. Design: randomized, controlled trial. Setting: general medical
more » ... s in the Grampian region of Scotland. Subjects: patients aged at least 65 years, with at least two chronic disease states who were taking at least four prescribed medicines regularly. Methods: pharmacists reviewed the drug therapy of 332 patients, using information obtained from the practice computer, medical records and patient interviews. In 168 patients, a pharmaceutical care plan was then drawn up and implemented. The 164 control patients continued to receive normal care. All outcome measures were assessed at baseline and after 3 months. Results: all patients had at least two pharmaceutical care issues at baseline. Half of these were identi®ed from the prescription record, the rest from notes and patient interview. Of all the issues, 21% were resolved by information found in notes and 8.5% by patient interview. General practitioners agreed with 96% of all care issues documented on the care plans in the intervention group. At the time of follow-up, 70% of the remaining care issues had been resolved in the intervention group, while only 14% had been resolved in the control group. There were no changes in medicine costs or health-related quality of life in either group. There were small increases in contacts with health-care professionals and slightly fewer hospital admissions among the intervention group than the control group. Conclusions: pharmacist-led medication review has the capacity to identify and resolve pharmaceutical care issues and may have some impact on the use of other health services.
doi:10.1093/ageing/30.3.205 pmid:11443021 fatcat:rqs4roiiq5cr5ogzypywhk63wy